ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,136Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 141

$1.3M Total Retail Price of All Prescriptions

Rank: 5 out of 141

599 Patients Receiving at Least One Drug in Part D
34% Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Oklahoma
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Brand Name Drugs*

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$117 was the average price of a prescription from this provider, compared to $113 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
CLONAZEPAM 499 95 98 B 1 5
RISPERIDONE 482 108 106 A 2 4
ESCITALOPRAM OXALATE 453 179 116 3 11
QUETIAPINE FUMARATE 448 136 112 A 4 3
ALPRAZOLAM 418 86 75 B 5 1
OLANZAPINE 353 86 90 A 6 14
MIRTAZAPINE 347 199 98 7 15
TRAZODONE HCL 295 66 80 8 2
DIVALPROEX SODIUM ER 286 157 75 9 28
CYMBALTA 278 130 51 10 12
OXCARBAZEPINE 270 12 48 11 33
CITALOPRAM HBR 247 50 65 12 9
ZOLPIDEM TARTRATE 231 62 56 13 7
LAMOTRIGINE 230 50 53 14 6
SERTRALINE HCL 228 82 52 15 8
ABILIFY 228 63 56 A 15 10
HYDROXYZINE PAMOATE 201 <11 65 R 17 19
LORAZEPAM 170 74 59 B 18 23
ZIPRASIDONE HCL 168 24 31 A 19 30
LISINOPRIL 162 73 46 20 56
NAMENDA 159 139 28 21 17
VENLAFAXINE HCL ER 142 20 36 22 18
HYDROCODONE-ACETAMINOPHEN 140 58 44 S3 23 59
MELOXICAM 136 37 36 24 88
TOPIRAMATE 134 26 28 25 35
BENZTROPINE MESYLATE 133 <11 35 R 26 16
SAPHRIS 133 13 30 A 26 96
BUPROPION XL 132 37 29 28 20
PROPRANOLOL HCL 126 27 26 29 39
INVEGA SUSTENNA 123 <11 27 A 30 38
LITHIUM CARBONATE 112 <11 23 31 26
SIMVASTATIN 109 47 24 32 65
TRIHEXYPHENIDYL HCL 105 16 21 R 33 32
ROPINIROLE HCL 105 23 26 33 98
OMEPRAZOLE 104 <11 29 35 54
DONEPEZIL HCL 104 99* 28 35 40
BUPROPION HCL SR 99 40 28 37 31
HALOPERIDOL 97 <11 25 A 38 41
DIVALPROEX SODIUM 93 51 20 39 29
METFORMIN HCL 91 34 26 40 66
BUSPIRONE HCL 85 <11 25 41 22
NORTRIPTYLINE HCL 85 43 18 41 129
PAROXETINE HCL 84 28 19 43 25
TEMAZEPAM 79 36 22 B 44 37
GABAPENTIN 75 25 30 45 21
FLUOXETINE HCL 73 25 16 46 13
LEVOTHYROXINE SODIUM 68 41 24 47 51
DIAZEPAM 65 17 11 B 48 27
AMLODIPINE BESYLATE 64 43 19 49 109
CARBAMAZEPINE 63 24 11 50 48
LATUDA 63 <11 17 A 50 47
CLOZAPINE 58 <11 <11 A 52 24
HYDROXYZINE HCL 56 <11 24 R 53 81
FUROSEMIDE 55 37 13 54 70
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.